LTS Lohmann Therapie-Systeme AG, commonly referred to as LTS, is a leading global player in the pharmaceutical and medical device industry, headquartered in Andernach, Germany. Founded in 1981, the company has established itself as a pioneer in transdermal drug delivery systems, offering innovative solutions that enhance patient compliance and therapeutic efficacy. With a strong presence in Europe, North America, and Asia, LTS focuses on the development and manufacturing of advanced drug delivery technologies, including patches and films. Their unique approach combines cutting-edge research with state-of-the-art production capabilities, ensuring high-quality products tailored to meet diverse medical needs. Recognised for its commitment to excellence, LTS has achieved significant milestones, solidifying its market position as a trusted partner for pharmaceutical companies worldwide.
How does LTS Lohmann Therapie-Systeme AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
LTS Lohmann Therapie-Systeme AG's score of 10 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
LTS Lohmann Therapie-Systeme AG, headquartered in Germany, currently does not have available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined in their initiatives. Without concrete figures or defined goals, it is challenging to assess their carbon footprint or climate strategy. However, the company may still be engaged in broader industry efforts to address climate change, aligning with global sustainability trends. As the landscape of corporate climate action evolves, it is essential for companies like LTS to establish measurable targets and transparent reporting to contribute effectively to climate mitigation efforts.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
LTS Lohmann Therapie-Systeme AG is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.